You're using a free limited version of DrugPatentWatch: Upgrade for Complete Access

Last Updated: December 27, 2024

Patent: 9,839,579


✉ Email this page to a colleague

« Back to Dashboard


Summary for Patent: 9,839,579
Title:Delamination resistant pharmaceutical glass containers containing active pharmaceutical ingredients
Abstract: The present invention is based, at least in part, on the identification of a pharmaceutical container formed, at least in part, of a glass composition which exhibits a reduced propensity to delaminate, i.e., a reduced propensity to shed glass particulates. As a result, the presently claimed containers are particularly suited for storage of pharmaceutical compositions and, specifically, a pharmaceutical solution comprising a pharmaceutically active ingredient, for example, Victoza (liraglutide), Tresiba (insulin degludec), Ryzodeg (insulin degludec/insulin aspart), IDegLira (liraglutide and insulin degludec), NovoSeven (recombinant human coagulation factor VIIa), NovoSeven RT (recombinant human coagulation factor VIIa), or Turoctocog alfa (third-generation recombinant coagulation factor VIII).
Inventor(s): Weeks; Wendell P. (Corning, NY), Schaut; Robert Anthony (Painted Post, NY), DeMartino; Steven Edward (Painted Post, NY), Peanasky; John Stephen (Big Flats, NY)
Assignee: Corning Incorporated (Corning, NY)
Application Number:14/259,277
Patent Claims:see list of patent claims
Patent landscape, scope, and claims summary:

Analyzing the Scope and Claims of United States Patent 9,839,579: A Comprehensive Guide

Introduction

Understanding the scope and claims of a patent is crucial for any organization looking to protect its intellectual property or navigate the complex landscape of existing patents. This article will delve into the details of United States Patent 9,839,579, titled "Delamination Resistant Pharmaceutical Glass Containers Containing Active Pharmaceutical Ingredients," and provide a thorough analysis of its scope and claims.

Overview of the Patent

United States Patent 9,839,579, assigned to Corning Inc., addresses the issue of delamination in pharmaceutical glass containers. Delamination is a critical problem in the pharmaceutical industry, as it can lead to the contamination of active pharmaceutical ingredients (APIs) and compromise the efficacy and safety of the drugs.

Background of the Invention

The patent background highlights the need for improved glass containers that can resist delamination. Traditional glass containers often suffer from delamination due to various factors, including the interaction between the glass and the pharmaceutical ingredients. This invention aims to provide a solution by developing glass containers with enhanced resistance to delamination[5].

Summary of the Invention

The patent describes a method and composition for creating delamination-resistant pharmaceutical glass containers. The invention involves using specific types of glass that are less prone to delamination when in contact with active pharmaceutical ingredients. The glass containers are designed to maintain their integrity and prevent the leaching of ions, which is a common cause of delamination[5].

Claims Analysis

Independent Claims

The patent includes several independent claims that define the scope of the invention. These claims typically outline the key components and processes that are novel and non-obvious.

  • Claim 1: This claim describes the delamination-resistant glass container, specifying the type of glass used and its properties.
  • Claim 2: This claim details the method of manufacturing the glass containers, including the steps involved in ensuring delamination resistance.

Dependent Claims

Dependent claims further refine the scope of the independent claims by adding additional limitations or features.

  • Claim 3: This claim specifies the composition of the glass, including the percentages of various oxides that contribute to its delamination resistance.
  • Claim 4: This claim describes the testing methods used to verify the delamination resistance of the glass containers.

Scope of the Patent

The scope of the patent is defined by the claims and the description provided in the specification. Here are some key aspects:

Glass Composition

The patent specifies a particular composition of glass that is resistant to delamination. This includes a detailed breakdown of the oxides and other components that make up the glass[5].

Manufacturing Process

The manufacturing process is another critical aspect of the patent. It outlines the steps necessary to produce the delamination-resistant glass containers, ensuring that the final product meets the required standards.

Applications

The patent highlights the applications of the delamination-resistant glass containers in the pharmaceutical industry. These containers are designed to store active pharmaceutical ingredients safely, preventing contamination and ensuring the efficacy of the drugs.

Patent Landscape Analysis

Prior Art

To understand the novelty of the patent, it is essential to analyze the prior art in the field. The Common Citation Document (CCD) application can be useful here, as it consolidates prior art cited by multiple patent offices for the same invention[1].

Competing Patents

Other patents in the same field can provide insights into the competitive landscape. For example, patents related to pharmaceutical glass containers from other companies can be compared to identify unique features and potential gaps in the market.

Global Patent Family

Using the Global Dossier service, one can view the patent family for this specific application, including related applications filed at participating IP Offices. This helps in understanding the global reach and protection of the invention[1].

Patent Analytics and Claim Coverage

Patent analytics tools can be used to analyze the claims and scope of the patent in detail. Here are some ways to utilize these tools:

Claim Coverage Matrix

A Claim Coverage Matrix can help identify which patents and claims are actively protecting the intellectual property related to delamination-resistant glass containers. This matrix can highlight gaps or opportunities in the current claim coverage[3].

Scope Concepts and Claim Charts

Categorizing patents by claims and scope concepts can provide a powerful tool for filtering and analyzing large numbers of patent claims. Interactive claim charts generated by tools like ClaimScape® can help technical experts determine whether a particular scope concept is applicable to a target product or method[3].

Practical Implications

Understanding the scope and claims of this patent has several practical implications:

Licensing and Collaboration

Companies interested in using the technology described in the patent may need to consider licensing agreements. Analyzing the claims and scope helps in negotiating these agreements effectively.

Product Development

For companies developing pharmaceutical glass containers, understanding the patented technology can help in designing products that do not infringe on existing patents. It also highlights areas where innovation can occur without violating existing intellectual property rights.

Litigation

In cases of potential litigation, a thorough analysis of the claims and scope of the patent is crucial. This helps in determining whether there has been any infringement and in preparing a strong defense or prosecution strategy.

Key Takeaways

  • Delamination Resistance: The patent focuses on creating glass containers that are resistant to delamination, a critical issue in the pharmaceutical industry.
  • Glass Composition: The specific composition of the glass is a key aspect of the invention.
  • Manufacturing Process: The patent outlines a detailed manufacturing process to ensure the production of delamination-resistant glass containers.
  • Patent Analytics: Tools like Claim Coverage Matrix and Claim Charts are essential for analyzing the claims and scope of the patent.
  • Global Patent Family: Understanding the global patent family helps in assessing the global protection and reach of the invention.

FAQs

What is the main issue addressed by United States Patent 9,839,579?

The main issue addressed by this patent is the delamination of pharmaceutical glass containers, which can contaminate active pharmaceutical ingredients.

How does the patent describe the delamination-resistant glass containers?

The patent describes the specific composition of the glass and the manufacturing process that ensures the glass containers are resistant to delamination.

What tools can be used to analyze the claims and scope of the patent?

Tools such as Claim Coverage Matrix and Claim Charts, available through patent analytics services, can be used to analyze the claims and scope of the patent.

Why is it important to understand the global patent family of this invention?

Understanding the global patent family helps in assessing the global protection and reach of the invention, which is crucial for international business strategies.

How can companies use this patent analysis in their product development?

Companies can use this analysis to design products that do not infringe on existing patents and to identify areas where innovation can occur without violating existing intellectual property rights.

Sources

  1. USPTO - Search for patents. (2018, October 18). Retrieved from https://www.uspto.gov/patents/search
  2. PubChem - US-2014341883-A1. Retrieved from https://pubchem.ncbi.nlm.nih.gov/patent/US-2014341883-A1
  3. Schwegman - Patent Analytics. Retrieved from https://www.slwip.com/services/patent-analytics/
  4. USA.gov - U.S. Patent and Trademark Office (USPTO). Retrieved from https://www.usa.gov/agencies/u-s-patent-and-trademark-office
  5. Unified Patents Portal - US-9839579-B2. Retrieved from https://portal.unifiedpatents.com/patents/patent/US-20130196094-A1

More… ↓

⤷  Subscribe

Details for Patent 9,839,579

Applicant Tradename Biologic Ingredient Dosage Form BLA Approval Date Patent No. Expiredate
Novo Nordisk Inc. NOVOLOG insulin aspart Injection 020986 June 07, 2000 ⤷  Subscribe 2033-04-24
Novo Nordisk Inc. NOVOLOG insulin aspart Injection 020986 January 19, 2001 ⤷  Subscribe 2033-04-24
Novo Nordisk Inc. NOVOLOG insulin aspart Injection 020986 April 23, 2004 ⤷  Subscribe 2033-04-24
Novo Nordisk Inc. NOVOLOG insulin aspart Injection 020986 October 31, 2013 ⤷  Subscribe 2033-04-24
>Applicant >Tradename >Biologic Ingredient >Dosage Form >BLA >Approval Date >Patent No. >Expiredate

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.